Cargando…
Plant sterols lower LDL-cholesterol and triglycerides in dyslipidemic individuals with or at risk of developing type 2 diabetes; a randomized, double-blind, placebo-controlled study
BACKGROUND: Managing cardiovascular disease (CVD) risk factors, e.g., dyslipidemia in type-2 diabetes mellitus (T2DM) is critically important as CVD is the most common cause of death in T2DM patients. This study aimed to investigate the effect of plant sterols (PS) on lowering both elevated low-dens...
Autores principales: | Trautwein, Elke A., Koppenol, Wieneke P., de Jong, Arienne, Hiemstra, Harry, Vermeer, Mario A., Noakes, Manny, Luscombe-Marsh, Natalie D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968034/ https://www.ncbi.nlm.nih.gov/pubmed/29795368 http://dx.doi.org/10.1038/s41387-018-0039-8 |
Ejemplares similares
-
A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia
por: Blom, Wendy A. M., et al.
Publicado: (2018) -
LDL-Cholesterol Lowering of Plant Sterols and Stanols—Which Factors Influence Their Efficacy?
por: Trautwein, Elke A., et al.
Publicado: (2018) -
Serum Concentration of Plant Sterol Oxidation Products (POP) Compared to Cholesterol Oxidation Products (COP) after Intake of Oxidized Plant Sterols: A Randomised, Placebo-Controlled, Double-Blind Dose–Response Pilot Study
por: Lin, Yuguang, et al.
Publicado: (2019) -
Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022) -
LDL-cholesterol-lowering effect of plant sterols and stanols across different
dose ranges: a meta-analysis of randomised controlled studies
por: Ras, Rouyanne T., et al.
Publicado: (2014)